West Pharmaceutical Services Inc. buy Bank of America Co.
Start price
13.12.24
/
50%
€310.30
Target price
13.12.25
€338.21
Performance (%)
-27.10%
End price
14.12.25
€226.20
Summary
This prediction ended on 14.12.25 with a price of €226.20. The price of West Pharmaceutical Services Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.10%. Dividends of €0.20 are taken into consideration when calculating the performance. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | -12.453% | -12.453% | -36.875% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% |
Comments by Bank_of_America_Co_ for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Bank of America Co. from $350.00 to $355.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€336.30
16.06.23
16.06.23
€369.72
16.06.24
16.06.24
-6.69%
17.06.24
17.06.24
